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Abstract
Of the Orthomyxoviridae family of viruses, only influenza A viruses are thought to exist as multiple subtypes and has non-
human maintenance hosts. In April 2011, nasal swabs were collected for virus isolation from pigs exhibiting influenza-like
illness. Subsequent electron microscopic, biochemical, and genetic studies identified an orthomyxovirus with seven RNA
segments exhibiting approximately 50% overall amino acid identity to human influenza C virus. Based on its genetic
organizational similarities to influenza C viruses this virus has been provisionally designated C/Oklahoma/1334/2011 (C/OK).
Phylogenetic analysis of the predicted viral proteins found that the divergence between C/OK and human influenza C
viruses was similar to that observed between influenza A and B viruses. No cross reactivity was observed between C/OK and
human influenza C viruses using hemagglutination inhibition (HI) assays. Additionally, screening of pig and human serum
samples found that 9.5% and 1.3%, respectively, of individuals had measurable HI antibody titers to C/OK virus. C/OK virus
was able to infect both ferrets and pigs and transmit to naive animals by direct contact. Cell culture studies showed that C/
OK virus displayed a broader cellular tropism than a human influenza C virus. The observed difference in cellular tropism
was further supported by structural analysis showing that hemagglutinin esterase (HE) proteins between two viruses have
conserved enzymatic but divergent receptor-binding sites. These results suggest that C/OK virus represents a new subtype
of influenza C viruses that currently circulates in pigs that has not been recognized previously. The presence of multiple
subtypes of co-circulating influenza C viruses raises the possibility of reassortment and antigenic shift as mechanisms of
influenza C virus evolution.
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Introduction
Influenza A, B and C viruses are members of the Orthomyxoviridae
family that can cause influenza in humans [1]. Influenza A viruses
exist in humans, various other mammal species, and birds;
migratory or domestic waterfowl are their largest reservoir.
Humans are thought to be the primary hosts and reservoir of
influenza B and C viruses, although both have been identified in
other hosts after reverse zoonotic transmission from humans.
While influenza B virus is a common seasonal human pathogen
similar to influenza A virus in its clinical presentation, influenza C
virus causes primarily upper respiratory tract infections in children
[2]. Clinical manifestations (cough, fever, and malaise) are
typically mild, but infants are susceptible to serious lower
respiratory tract infections [3]. Influenza C viruses co-circulate
with influenza A and B viruses and causes local epidemics [4,5].
Six genetic and antigenic lineages of influenza C viruses have been
described, and as in influenza B viruses, are considered
monsubtypic [6,7]. Co-circulation of multiple subtypes of influen-
za allows for rapid viral evolution through the process of antigenic
shift, a property previously only shown for influenza A viruses.
Thus, both influenza B and C viruses do not have pandemic
potential. In contrast, the Influenza A genus includes 17
hemagglutinin and 9 neuraminidase subtypes, and reassortment
among different subtypes has repeatedly generated pandemic
viruses to which the human population is naı¨ve [8–10]. It is the
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animal reservoirs of diverse influenza A viruses that give them the
unique property within orthomyxoviruses of causing human
pandemics.
Aside from humans, influenza C virus has been isolated only
from swine in China (in 1981) [11]. Genetic analysis showed a
close relation between Japanese human and Chinese swine
influenza C isolates [12,13]. Serological surveys in Japan and
the United Kingdom found 9.9% and 19% of swine, respectively,
to have positive HI antibody titers to human influenza C viruses,
suggesting that the virus is not uncommon in swine [14,15]. Swine
inoculated with influenza C virus had mild respiratory disease and
transmitted the virus to naive swine by direct contact [11]. Here
we characterize an orthomyxovirus isolated from a clinically ill pig
and show that the virus is distantly related to human influenza C
virus and readily infects and is transmissible in both ferrets and
pigs. Genetic and antigenic analysis suggest that this virus
represents a new subtype of influenza C virus, raising the
possibility of reassortment and antigenic shift as mechanisms for
influenza C virus evolution which could pose a potential threat to
human health.
Results
Identification of an Influenza C virus in Pigs
In April 2011, nasal swabs from 15-week old swine exhibiting
influenza-like illness were submitted to Newport Laboratories,
Worthington, Minnesota, for virus isolation. Real-time reverse
transcription PCR (rt-RT-PCR) was negative for influenza A virus
[16]. In swine testicle (ST) cells, the viruses caused influenza-like
cytopathic effects (CPE) by day 3. The cell culture harvests were
again negative for influenza A virus by rt-RT-PCR. Electron
microscopic (EM) studies of the cell cultures demonstrated features
characteristic of an Orthomyxovirus (Fig. 1). Negative-staining
EM showed enveloped spherical to pleomorphic viral particles
approximately 100–120 nm in diameter (Fig. 1A). The virion
surface contained dense projections 10–13 nm in length and 4–
6 nm in diameter. Thin-section EM studies of infected cells
revealed filamentous budding of virions from the plasma
membrane (Fig. 1B). These data strongly suggested the virus to
be a member of the family Orthomyxoviridae. Enzymatic assays
revealed that the virus had negligible neuraminidase but
detectable O-acetylesterase activity using 4-nitrophenyl acetate,
suggesting it to be a member of the influenza C genus. However,
further RT-PCR analysis was negative for influenza B and C
viruses [17]. RT-PCR or PCR assays to detect porcine reproduc-
tive and respiratory syndrome virus, porcine coronavirus, and
porcine circovirus were also negative (data not shown).
Genome sequencing and analysis
The virus was purified by ultracentrifugation and sequenced on
an Ion Torrent Personal Genome Machine. De novo genome
assembly found that most of the sequence reads mapped to seven
contigs of approximately 1000–2400 bp. Open reading frame
(ORF) analysis of the contigs found a single ORF for all segments,
with the exception of two ORFs for the smallest contig. BlastP
searches of the putative proteins identified modest homology to
human influenza C virus, suggesting that this virus was distantly
related to human influenza C virus (Table 1). Consequently, the
virus was provisionally designated C/swine/Oklahoma/1334/
2011 (C/OK). The genomic coding sequences of all segments
were determined and used for subsequent genetic and phyloge-
netic analyses.
Because PB1 is reported to be the most conserved influenza
virus protein, it is frequently used to evaluate the evolutionary
relationship among influenza viruses [18]. We firstly performed
ClustalW alignment of predicted polymerase basic 1 (PB1) amino
acid sequences of influenza A, B, and C viruses. C/OK shared
approximately 69%–72% mean pairwise identity to influenza C
viruses and 39%–41% identity to influenza A and B viruses.
Homology between the influenza A and B PB1 proteins was
approximately 61% and intrasubtype PB1 proteins of influenza A
viruses are extremely conserved reaching up to 90% homology.
PB1 protein alignments indicated that C/OK was more closely
related to influenza C viruses than to influenza A and B viruses but
more distant from individual members of human influenza C type.
Pairwise identity between C/OK and influenza C viruses was
considerably lower for polymerase basic 2 (PB2) and polymerase 3
(P3) (53% and 50%, respectively). In influenza A and B viruses
segment 3 is referred to as polymerase acidic (PA) protein because
of its pKa of approximately 5.2. Conversely, segment 3 of
influenza C viruses encodes a polymerase with a neutral pH (pKa
,7.2) and is referred to as P3 [18]. Interestingly, the predicted
pKa of C/OK P3 is 6.2, which is between those of the influenza
A/B and influenza C viruses.
In influenza C virus, a hemagglutinin esterase (HE) protein is
responsible for receptor binding, receptor destroying (acetylester-
ase), and membrane fusion activities, whereas in influenza A and B
viruses, separate hemagglutinin (HA) and neuraminidase (NA)
proteins perform these functions in a cooperative fashion. The
pairwise sequence identity of the C/OK and human influenza C
virus HE proteins was 53%, similar to the 49% observed across the
influenza A HA subtypes [10] but clearly higher than the HA
homology (approximately 25–30%) between influenza A and B
viruses. NS1 of C/OK virus had the lowest homology to its
counterpart in human influenza C viruses (29%–33% identity),
similar to the less conserved influenza A and B NS1 proteins (22%
identity).
Like PB1, the nucleoprotein (NP) and matrix (M) proteins are
highly conserved among members of each genus of influenza
viruses. Despite the high intragenic homology (.85%), NP and
M1 are highly variable among the three influenza virus genera and
their intergenic homologies are only about 20–30%, which serve
Author Summary
Influenza C viruses infect most humans during childhood.
Unlike influenza A viruses, influenza C viruses exhibit little
genetic variability and evolve at a comparably slower rate.
Influenza A viruses exist as multiple subtypes and cause
disease in numerous mammals. In contrast, influenza C
viruses are comprised of a single subtype in its primary
human host. Here we characterize a novel swine influenza
virus, C/swine/Oklahoma/1334/2011 (C/OK), having only
modest genetic similarity to human influenza C viruses. No
cross-reaction was observed between C/OK and human
influenza C viruses. Antibodies that cross react with C/OK
were identified in a significant number of swine but not
human sera samples, suggesting that C/OK circulates in
pigs. Additionally, we show that C/OK is capable of
infecting and transmitting by direct contact in both pigs
and ferrets. These results suggest that C/OK represents a
new subtype of influenza C viruses. This is significant, as
co-circulation of multiple subtypes of influenza allows for
rapid viral evolution through antigenic shift, a property
previously only shown for influenza A viruses. The ability of
C/OK to infect ferrets along with the absence of antibodies
to C/OK in humans, suggests that such viruses may
become a potential threat to human health.
Novel Influenza C Virus
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as genus-specific antigens that distinguish between the influenza A,
B, and C viruses [19,20]. The amino acid sequence of the C/OK
NP had 38%–41% identity to influenza C viruses. Unspliced
mRNA from the C/OK M segment 6 encodes the polyprotein
P42, which is cleaved by a signal peptidase to yield M19 and CM2
[21]. P42 was analyzed due to unknown mRNA splice and protein
cleavage sites used by C/OK virus to generate M1 and CM2,
respectively. The C/OK P42 had 38% identity to influenza C
viruses. Relative low homologies of NP and M proteins between
C/OK and human influenza C viruses are interesting but seem to
be consistent with pairwise protein homology analysis for
polymerase and non-structural proteins.
In addition to the coding region, each RNA segment of
influenza viruses also contains noncoding (NC) regions at its 59 and
39 ends. These NC regions are highly conserved, particularly those
at the terminal ends, among the genome segments of each species.
These regions form panhandle structures by partial inverted
complementarity between the 59 and 39NC regions and play a
critical role in genome replication and packaging [22–25]. Using
59 and 39 RACE coupled with direct PCR sequencing by the
Sanger method, we determined the complete sequences of the 39
and 59 NC regions of the seven segments of the C/OK virus
(Table S1). The 39 and 59 NC region sequences of C/OK genome
segment were similar to those of human influenza C viruses with
the exception of one nucleotide (position 5 from the 39-terminus)
and polymorphism at position 1 of the 39terminus.
Viral RNA packaging sequences are composed of the 59 and
39NC regions and the terminal coding sequences of each segment.
Incompatibility between homologous segment packaging sequenc-
es has been shown to prevent segment reassortment [26]. Nearly
identical NC sequences at the proximal ends of seven RNA
segments observed between C/OK and human influenza C
Figure 1. Ultrastructural analysis of C/OK virus isolate in cell culture as observed by negative stain (A) and thin-section (B) electron
microscopy. (A) Negative stain shows features of an orthomyxovirus particle (Bar = 200 nm) (B) Infected cells visualized with uranyl acetate and lead
contrast. Note assembly and budding of virions at the apical pole. Free spherical virions 70–90 nm in diameter present surface spikes and internal
electron-dense dots. Bar = 500 nm.
doi:10.1371/journal.ppat.1003176.g001
Table 1. BlastP analysis of the eight putative open reading frames of C/swine/Oklahoma/1334/2011.
ORF (Amino acid) Best blast hit (virus; accession number) Identity (%) Positive (%)b
772 PB2 (C/Johannesburg/1/66; Q9IMP3) 53 71
758 PB1 (C/Johannesburg/1/66; AF170575) 72 85
710 P3 (C/Ann Arbor/1/50; NC_006309) 50 66
664 HEF (C/Catalonia/1318/2009; HM748631) 53 69
552 NP (C/Johannesburg/4/67; BAL72794) 39 59
387 P42a (C/Taylor/1233/47; FLCT123347) 38 58
243 NS1 (C/Hiroshima/248/2000; AB099621) 33 48
168 NS2 (C/Sao Paulo/378/82; AB035366) 29 48
aM1 and M2 proteins were not analyzed because the splicing donor and acceptor sites are not predictable due to sequence variation of M segments between C/OK and
human influenza C viruses.
bPositive value indicates the degree of similarity between proteins.
doi:10.1371/journal.ppat.1003176.t001
Novel Influenza C Virus
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viruses suggest a potential for viral segment reassortment in
nature. Significant variability was observed in the NC regions
immediately adjacent to each coding region for C/OK as
compared to human influenza C; however previous work
demonstrated that the highly conserved NC region at the proximal
ends of the segment plays a key role in transcription and
replication [27].
Phylogenetic analysis
Our phylogenetic analysis used representative influenza A, B,
and C viruses (Fig. 2). The segments encoding the C/OK virus
PB2, PB1, P3, NP, M and NS clustered most closely with influenza
C viruses, suggesting that these C/OK genes diverged from known
human influenza C viruses after they diverged from influenza A
and B viruses but before they diverged from previously sequenced
influenza C viruses. As HE does not occur in influenza A and B
viruses, only influenza C viruses were included in that analysis.
Previous studies have found that multiple genetically and
antigenically distinct but related lineages of influenza C virus co-
circulate and frequently reassort [6,28–30]. Given this evidence, it
is puzzling that the seven segments of C/OK are only slightly to
moderately homologous to characterized influenza C viruses.
Serological survey
An HI assay was performed to determine the antigenic cross-
reactivity and seroprevalence of C/OK virus in humans and
swine. The assay included reference strains of influenza A, B, and
C genera and their matched antisera (Table S2). No cross-
reactivity was observed between C/OK virus and heterologous
antisera. For the human cohort, we used a set of 316 serum
samples.
These sera originated from patients recruited in the Greater
Vancouver area of British Columbia, Canada, or in the vicinity
of the Greater Hartford area of Connecticut during the 2007–
2008 and 2008–2009 influenza seasons as described in Marcelin
et al. [31]. All but four of these sera had undetectable C/OK HI
titers (#10). Three had HI titers of 20, but each of these also
had high titers (160, 320, and 1280) to the human influenza C
isolate C/Yamagata/10/1981. The remaining positive sample
had a HI titer to C/OK of 40 with no corresponding titer to the
human influenza C isolates tested. The low titers and number of
positive samples (1.3%) obtained are inconclusive in determin-
ing circulation of C/OK in the human population, especially as
thirty-four percent of the serum samples had HI titers $20 to
C/Yamagata/10/1981 which is consistent with previous studies
showing approximately 60% of elderly humans retain influenza
C virus antibody titers [32]. Swine serum samples (n= 220)
submitted to Newport Laboratories for unrelated diagnostic
testing by commercial swine production facilities nationwide
were similarly analyzed. Sera were collected from pigs aged 3–
20 weeks from March through September 2011. HI titers
(range, 10–80) were detected in 9.5% of samples, with a GMT
of 20.7. To assess the specificity of the HI titers to C/OK in
swine sera, we performed HI assays using the human influenza
C virus C/Taylor/1233/47 (C/Taylor). Only 2.8% of the swine
sera had measurable titers (range, 10–20). Taken together, these
results suggest that C/OK virus circulates in swine populations
but is not widespread in humans. Further serologic studies
focusing on individuals occupationally exposed to swine are
required.
Infection and transmission in ferrets and pigs
To better understand the pathogenesis and epidemiology of C/
OK, we performed infection studies with ferrets and swine. We
first addressed the zoonotic potential of C/OK virus by
conducting a pathogenesis and transmission study in the ferret
model. After intranasal inoculation of ferrets, C/OK virus was first
detected in nasal washes on day 3 (mean titer, 3.3 log10 TCID50/
mL) (Fig. 3). C/OK virus was first detected in ferrets exposed by
direct contact to inoculated ferrets on day 7, reaching a mean titer
of 4.3 log10 TCID50/mL by day 10. Virus was not detected in
ferrets exposed to respiratory droplets. No clinical signs of disease
were observed. In the tissues of ferrets on day 5 post-inoculation
(p.i.), a mean titer of 3.9 log10 TCID50/mL was observed in the
nasal turbinates, but no virus was detected in the upper and lower
trachea, lung, small intestine, liver, or spleen. Histopathological
examination of lung tissues showed no typical influenza lesions.
These results are consistent with a previous study that investigated
human influenza C replication in ferret alveolar macrophage cells
where viral replication with titers .104 egg infectious dose 50
from days 4 to 9 were measured with no cytopathic effects [33]. All
ferrets that were inoculated or exposed by direct contact and 1/3
of the ferrets exposed to respiratory droplets seroconverted 3 weeks
after exposure as measured by HI assay (GMT=780). To assess
the pathogenicity and transmissibility of the virus in swine, we
similarly challenged swine intranasally with C/OK (Fig. S1). Virus
was first detected in nasal swabs on day 3 p.i. by using an rt-RT-
PCR method specifically developed for C/OK virus. Virus
shedding peaked at day 8 p.i. and remained detectable on day
10. Virus was detected in swine exposed by direct contact on days
7 and 9 after exposure. No clinical signs of illness were observed.
Lung samples collected from inoculated swine on day 7 p.i.
showed no evidence of the virus by rt-RT-PCR. Histopathological
examination of lung tissues showed no typical influenza lesions.
Sera collected on day 14 p.i. from donor pigs were positive for
antibodies to C/OK virus in an HI assay (GMT=30.3). All 5 pigs
were positive for antibodies to C/OK. Additionally, 2 of the 5
direct contact pigs seroconverted by day 13 post exposure. These
data suggest that in animals the replication kinetics is slower for C/
OK virus than for influenza A viruses and infection in both swine
and ferrets was limited to the upper respiratory tract. The ability of
C/OK to readily transmit to contact ferrets suggests that a level of
transmission potential to humans is possible. Zoonotic H5N1 and
H9N2 influenza A viruses are typically unable to transmit in
ferrets.
Cellular tropism
We compared in vitro cellular tropism between C/OK and
human influenza C viruses by rt-RT-PCR in several cell lines,
including ST, adenocarcinomic human alveolar basal epithelial
(A549), Madin-Darby canine kidney (MDCK), Green African
monkey kidney (Marc-145), human rectal tumor (HRT-18G),
baby hamster kidney (BHK-21) and porcine kidney (PK-15)
cells. C/OK replicated, in order of highest replication, in ST,
MDCK, Marc-145, HRT-18G and A549 cells (Fig. S2A).
Minimal replication was observed in BHK-21 and PK-15 cells.
In marked contrast, the human influenza C virus C/Taylor
showed poor growth and replicated only in ST and HRT-18G
and not in other cells tested (Fig. S2B). It should be noted
however that cultivation of influenza C/Taylor virus was
performed at 33uC, the optimal temperature that is typically
used to propagate human influenza C virus [34]. This virus
failed to replicate at 37uC in our hands which differs from the
C/OK virus that can replicate efficiently at this temperature
(data not shown). These results suggest that C/OK has a
broader cellular tropism than C/Taylor and is also not
restricted at elevated temperatures for replication.
Novel Influenza C Virus
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Figure 2. Phylogenetic trees of the coding regions of the seven segments of C/OK virus. Maximum-likelihood analysis in combination with
1000 bootstrap replicates was used to derive trees based on the nucleotide sequences encoding respective proteins. A scale representing the
number of nucleotide changes is shown in each panel. The trees are shown for PB2, PB1, P3, HE, NP, P42, and NS segments. Bootstrap values are
shown above branches to the left of major nodes.
doi:10.1371/journal.ppat.1003176.g002
Novel Influenza C Virus
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Structural basis for the observed difference in cellular
tropism
The influenza C virus utilizes the 9-O-acetyl-N-acetylneurami-
nic acid (Neu5,9Ac2) as the primary receptor for attachment to the
cell surface to initiate infection [35]. The receptor binding
specificity and affinity are mainly determined by the 9-O-acetyl
group of the Neu5,9Ac2 [36]. As a result, the virus encodes a
sialate-O-acetylesterase, not neuraminidase, in order to release
virions from infected cells by cleavage of the 9-O-acetyl group
[37]. To provide structural insights to the observed different
tropism, we conducted structural modeling of the C/OK HE
protein in complex with the receptor based on the solved X-ray
crystallographic structure of a human influenza C virus (C/
Johannesburg/1/66) HE protein [36]. The overall 53% sequence
identity between the two HE proteins allows us to predict
important structural features such as the receptor-binding pocket
and the enzymatic active site of the C/OK HE protein. Based on
the assumption that the HE protein uses similar sites for function,
our structural modeling analysis identified a conserved enzymatic
active site but revealed a variable receptor-binding pocket between
two HE proteins (Figs. 4 and S3). These results are consistent with
the observed difference in cellular tropism. For example, both HE
proteins possess an identical catalytic triad: S71/H369/D365 for
C/Johannesburg and S73/H375/D372 for C/OK (Fig. 4A). The
other two substrate-interacting residues for optimal enzymatic
function are also completely conserved in the two HE proteins
(G99/N131 for C/Johannesburg and G101/N133 for C/OK). In
addition, both HE proteins utilize two conserved arginine residues
for substrate binding (R72/R332 for C/Johannesburg and R74/
R342 for C/OK). The conserved enzymatic site between C/
Johannesburg and C/OK suggests that C/OK utilizes 9-O-acetyl
sialic acid as the cellular receptor for infection.
Analysis of the receptor-binding pocket formed by a cluster of
noncontiguous amino acid residues revealed some interesting
similarities and differences between C/Johannesburg and C/OK.
The influenza C HE protein uses two binding pockets for
recognizing the receptor: one binds to the 9-O-acetyl group while
the other engages the 5-N-acetyl group [36]. As shown in Fig. 4,
the 5-N-acetyl binding pocket of C/OK HE becomes smaller as
compared to that of C/Johannesburg due to LRW substitution,
i.e. L198 in C/Johannesburg is replaced by W201 at C/OK HE
position 201; the large rigid aromatic side-chain of W201 extends
Figure 3. Replication of C/OK virus in ferrets challenged intranasally (donors) or exposed by direct or aerosol contact. Three ferrets
(donor ferrets) were inoculated intranasally with 106 TCID50 of C/OK virus in 1 ml of sterile PBS. Two inoculated ferrets were also housed separately for
virus titration and histopathology in organs. At 23 h p.i., each of the three remaining donor ferrets was housed in a cage with one naı¨ve direct-
contact ferret (n = 3). An additional ferret (n = 3) was placed in an adjacent cage separated from the donor’s cage by a two layers of wire mesh (,5 cm
apart) that prevented physical contact but allowed the passage of respiratory droplets. To monitor virus shedding, nasal washes were collected from
ferrets 3, 5, 7, and 10 days p.i. Virus was titrated in ST cells as log10 TCID50/ml and values shown are the mean 6 standard error.
doi:10.1371/journal.ppat.1003176.g003
Novel Influenza C Virus
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into the binding pocket (Fig. 4B, 4C, and 4D). The binding
pocket for the 9-O-acetyl group is nearly identical in C/
Johannesburg and C/OK, implying the utility of the 9-O-
acetyl-neuraminic acid for C/OK virus infection. For interacting
with the 9-O-acetyl group, human influenza C viruses utilize a
cluster of amino acid residues Y141, F239, Y241, R250, and
R302, which is also used by the C/OK virus except for two
phenylalanine residues replacing tyrosine (Y141) and arginine
(R250), respectively. We hypothesize that these amino acid
differences may alter the binding specificity and affinity of the HE
protein to the receptor that in turn result in the observed
difference in cellular tropism between two viruses.
Discussion
Previous studies have indicated the presence of multiple lineages
and antigenic groups in influenza virus type C virus [28–30].
Despite such variation, it has been long viewed that the influenza
C viruses consist of a single subtype [1]. In contrast to this
conventional wisdom, here we describe the characterization of a
novel influenza C virus from swine with influenza-like illness. The
phylogenetic analyses, together with the observations of genomic
structure, indicated that this novel virus is more closely related to
influenza C than to other members of the Orthomyxoviridae family
including influenza A and B viruses, and suggested that the virus
Figure 4. Structural comparisons of C/OK and human C HE receptor-binding pocket and substrate-binding site. (A) Superposition of
the esterase active site of C/OK (magenta sticks) and human C/Johannesburg/1/66 (gray sticks). The potential hydrogen bonds shown were from a
previous study and were indicated as dashed line [36]. The analog of 9-O-sialic acid, 9-acetamindo-sialic acid a-methylglycoside, was colored cyan. (B)
Superposition of the sialic acid binding site of the receptor binding domain of C/OK (magenta sticks) and human C/Johannesburg/1/66 (gray sticks).
Hydrogen bonds between residues of C/Johannesburg/1/66 and sialic acid were shown as dashed yellow line. The structure of C/Johannesburg/1/66
HEF was transparently shown in cartoon mode (gray). (C) Electrostatic surface of human C/Johannesburg/1/66 HE. Blue colored region has strong
positive potential while red colored region has negative potential. (D) Electrostatic surface of C/OK HE. For both (C) and (D), the nine carbons of sialic
acid are numbered.
doi:10.1371/journal.ppat.1003176.g004
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could be considered a new subtype of influenza C virus, despite its
divergence from human influenza C viruses, which is similar to the
divergence between influenza A and B viruses. Identification of
this virus was not an isolated case, as we have identified four
additional swab samples from swine showing influenza-like
symptoms that were positive for this virus in a RT-PCR assay
(data not shown). These samples were collected from different pig
farms across the U.S. between 2010 and 2012.
The finding that influenza C virus, like influenza A, harbors
multiple subtypes is significant. It suggests the possibility of
reassortment between subtypes, which could potentially generate
viruses with phenotypes that may pose a threat to public health.
Nine and a half percent of surveyed swine possessed antibodies
specific to C/OK indicating that this previously unidentified virus
circulates in U.S. swine. A causal relationship is evidently
supported by the experimental infection of pigs. As such,
reassortment may occur between C/OK and human influenza
C viruses in pigs because both viruses can infect and transmit
among pigs and because swine has been documented in serving as
a mixing vessel for reassortment of influenza A viruses [38,39].
Despite a lack of compelling evidence of C/OK virus infection
in humans, we suspect that the virus may infect and replicate in
the human population because of the following reasons: First of all,
the virus infects and transmits in ferrets, a surrogate for human
influenza pathogenesis studies. The ability of C/OK virus to
readily transmit to contact ferrets suggests that a level of
transmission potential to humans is possible. Second, C/OK virus
displays a broader cellular tropism compared to human influenza
C virus, and this virus seems quite plastic in terms of propagation
because high temperatures such as 37uC do not restrict its
replication at least in cell culture. Human influenza C virus causes
a mild respiratory disease in humans and the infection is normally
confined to the upper respiratory tract, although occasionally it
can also cause lower respiratory infection [5]. Considering that C/
OK virus varies significantly from currently circulating human
influenza C viruses in the amino acid sequences of predicted
proteins, assessment of clinical disease in humans, particularly in
children, caused potentially by C/OK is justified. Knowledge of its
presence in human clinical settings is important to any future
attempt to manage and control the disease outbreak. By using the
nucleotide sequence of C/OK virus reported in this work, sensitive
and specific diagnostic methods can be developed to investigate
the pathogenesis and epidemiology of this novel virus in humans.
Influenza C virus is not readily isolated and cultured, and
primary isolation can be challenged. The obstacle is largely due to
a lack of suitable cell lines for influenza C virus isolation as
suggested previously [5,34]. In contrast, identification and
cultivation of the C/OK in the ST cell line is relatively
straightforward. The emerging but puzzling question then is why
this virus has not been identified until now. We suspect that several
factors including use of less susceptible cell lines and complicated
co-infection often involving influenza A viruses and other viruses
having the capacity to agglutinate red blood cells may account for
the previous failures in identifying this virus. Alternatively, the C/
OK virus may have spread to swine in recent years from an
unknown animal reservoir. On-going retrospective seroepidemio-
logical analyses will help to address this question.
The difference in cellular tropism between C/OK and human
influenza C may be a result of differences in the receptor
recognition of the HE protein. To explore the possible structural
origins of this difference, we created a homology model for C/OK
using the crystal structure of the influenza C HE protein (Fig. S3).
The high sequence identity (53%, Fig. S3) between C/OK HE
and influenza C suggest that the quality of this model will be high,
given previous work in homology modeling and structure
validation for influenza A and B HA proteins in which similar
sequence similarities gave RMSD errors of ,1 A˚ [40,41]. The
predicted receptor binding for C/OK HE appears on the top face
of the receptor binding domain similar to human influenza C HE
protein and remote homolog HE proteins of other viruses such as
coronavirus and torovirus (,30% sequence similarity to influenza
C HE) [42]. Here, four out of nine residues of the receptor binding
site and residues around the binding pocket of HE of human
influenza C are retained in that of C/OK (Fig. S4). Previous work
has shown that receptor binding specificity and affinity are
sensitive to substitutions in the receptor binding site of HE and HA
[43,44]. Examining the predicted receptor-binding site of C/OK
HE revealed changes in the receptor binding site relative to
human influenza C HE. The most notable difference is a
reduction in the size of the 5-N-acetyl binding pocket of C/OK
HE relative to C HE due to the L198 in C HE being replaced by
W in C/OK HE (Fig. 4). Alternatively, the binding pocket for the
9-O-acetyl group is similar between the two HE proteins (Fig. 4).
We speculate that these differences may indicate that C/OK HE
utilizes a different substrate than influenza C HE. Further
experimental verifications of are required to test this prediction.
It has been suggested that influenza A, B, C viruses have a
common precursor, and of the three virus types, influenza A and B
viruses are much more similar to each other in genome
organization and protein homology than to C viruses, which
suggests that influenza C virus diverged well before the split
between A and B viruses [9]. Numerous studies have shown that
influenza C viruses have the slowest evolutionary rate among
influenza viruses [13,19,45–47]. One theory is that influenza C
viruses, like influenza B viruses, are close or at an evolutionary
equilibrium in humans, whereas influenza A viruses have not yet
reached an equilibrium [48]. Consistent with this hypothesis is that
only a single subtype is thought to exist for influenza B and C
viruses and humans, not other mammals, are the primary hosts of
influenza B and C viruses. The discovery of C/OK in pigs, being
distantly related to human C viruses, seems to challenge these
accepted views and warrant future studies of influenza C virus
evolution.
Virus nomenclature is the subject of discussion and there is still
a possibility that C/OK virus can be assigned as the prototype of a
new genus of the Orthomyxoviridae family. Most compelling evidence
in support of the tentative designation of the C/OK virus are (i)
seven genomic segments, (ii) 39 and 5’s NC regions similar to those
of human influenza C viruses, and (iii) HE protein sharing
approximately 53% homology with that of influenza C viruses.
The last parameter is the primary determinant to classify subtypes
of influenza A virus. However, the overall divergence between C/
OK and human influenza C viruses is similar to that observed
between influenza A and B viruses and argues for classification of
C/OK into a potential new virus genus. Influenza A, B, and C
viruses are classified on the basis of antigenic differences between
their nucleoprotein (NP) and matrix (M) proteins [1]. Intriguingly,
only modest homologies of these structural proteins between C/
OK and human influenza C further confound the provisional
classification for this newly discovered virus. Recently the family
Orthomyxoviridae was expanded by including two novel genera,
Thogotovirus, consisting of three viruses that infect birds and ticks,
as well as the genus Isavirus, consisting of infectious salmon
anemia virus [49,50]. For the novel swine influenza virus reported
here, perhaps not until attaining more detailed serological,
virological, and molecular data, a final classification of this virus
can be made. Of particular importance are reassortment
experiments between C/OK and human influenza C viruses.
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While similar, two discrepancies were found in the NCR’s of C/
OK as compared to human influenza C viruses. It is not known
whether these mutations prevent reassortment between C/OK
and human influenza C viruses. Preliminary reassortment
experiments between C/OK and C/Taylor have been performed
and have failed to identify reassortant viruses. More detailed
studies are underway.
In summary, we identified a novel influenza C virus that
infects and spread among pigs or ferrets by direct contact. The
ability of this novel pathogen to infect ferrets; a surrogate for
human influenza infection suggests that such viruses may
become a potential threat to human health. Our finding
reported in the present study raises several interesting
questions. Does this influenza C-like virus have the capability
of generating a viable reassortant with currently circulating
human C viruses? If so, could such a reassortment allow
influenza C virus to diverge and to have greater pathogenicity?
When and where did this novel virus emerge? What is its
animal reservoir in nature? Future elucidation of these
questions will provide insights into the ecology, virology, and
pathobiology of influenza C virus.
Materials and Methods
Ethics statement
Ferret experiments were conducted in an Animal Biosafety
Level 2+ (level 2 with enhanced biocontainment for pandemic
H1N1 influenza A virus) facility at St. Jude Children’s Research
Hospital, in compliance with the policies of the National Institutes
of Health and the Animal Welfare Act and with the approval of
the St. Jude Children’s Research Hospital Animal Care and Use
Committee (IACUC No. 428). Pig experiments were performed at
Newport Laboratories under biosafety level 2 conditions in
accordance with the Guide for the Care and Use of Agricultural
Animals in Research and Teaching and were approved by the
Institutional Animal Care and Use Committees at Newport
Laboratories (IACUC No. 02-2012).
Virus isolation
Nasal swabs were collected from 15-week-old pigs exhibiting
influenza-like illness at a commercial swine production facility in
Oklahoma, USA, in April, 2011. Viral isolation was performed on
swine testicle cells and cytopathic effects were evident by day 3
post inoculation. Detailed information on cell culture conditions is
available in SI Appendix, Supplementary Materials and Methods.
Hemagglutination assays were performed using chicken red blood
cells.
Genome sequencing and analysis
C/OK was concentrated from ST cell supernatants by
ultracentrifugation and subsequently purified through a 20%
sucrose cushion by ultracentrifugation. Viral RNA was isolated
using the Qiagen Viral RNA Isolation Kit and converted to
cDNA using random primers included in the GoScript Reverse
Transcription Kit (Promega). The cDNA was made double
stranded with DNA polymerase and used to construct a library
for Ion Torrent Sequencing. Detailed sequencing methodology
is available in SI Appendix, Supplementary Materials and
Methods.
Contigs were assembled de novo by using SeqMan NGen
software (DNAStar). Contigs encoding proteins with homology
to influenza C proteins were identified by BlastP analysis. The
genome sequence of C/OK was submitted to Genbank under
accession no. JQ922305-JQ922311, relating to segments 1–7,
respectively. Phylogenetic analyses were performed by using Mega
5 software [51]. Evolutionary analyses were conducted by using
the Maximum Likelihood algorithm, and the tree topology was
verified by performing 1000 bootstrap replicates.
Real Time Reverse Transcription PCR Assay
The PB1 sequence was used to design primers and a Taqman
probe for detection of C/OK (position of primers and probe in
PB1 gene: forward, nucleotides 1420–1439; reverse, nucleotides
1555–1535; probe, 1482–1460). Viral RNA was extracted by
using the MagMAX-96 viral RNA isolation kit (Life Technologies)
according to the manufacturer’s instructions. rt-RT-PCR was
performed by using QIAGEN Quantitect RT-PCR with the C/
OK primers and probe. Method specificity was assessed by using
influenza A, B, and C reference viruses, and no cross-reaction was
observed.
Cell culture and virus replication
Swine testicle (ST) cells were grown in DMEM containing
5% fetal bovine serum. Influenza C/Taylor/1233/47 virus was
provided by BEI Resources (NIAID). For infection, cell
medium was replaced with DMEM and viral inoculum was
added at a multiplicity of infection of 0.001. Viral growth
studies were performed on a monolayer of ST, A549, Marc145,
HRT-18G, BHK-1, or PK-15 cells using an inoculum of 1.0–
3.0 TCID50/ml in duplicate (multiplicity of infection 1610
25–
161023). C/OK virus replication was performed at 37uC while
C/Taylor replication was done at 33uC. Samples were
removed at 0, 24, 48, and 72 hours p.i. and virus was titrated
by rt-RT-PCR. Experiments were performed three times in
duplicate.
Serology
Human sera were treated with receptor-destroying enzyme
(Denka Seiken Co., Tokyo, Japan) overnight at 37uC, heat-
inactivated at 56uC for 30 min, diluted 1:10 with PBS, and tested
by hemagglutination inhibition (HI) assay with 0.5% packed
chicken red blood cells (cRBCs) as described in the WHO Manual
on Animal Influenza Diagnosis and Surveillance [52].
Assessment of virus pathogenicity and transmission in
ferrets
The pathogenicity and transmission of the virus was tested in 3-
to 4 month-old male ferrets. Detailed pathogenicity and transmis-
sion methodology is available in SI Appendix, Supplementary
Materials and Methods. Three donors were inoculated intrana-
sally under light isoflurane anesthesia with 106 TCID50 of swine/
Oklahoma/1334/2011 virus in 1 ml of sterile PBS. Two
additional ferrets were similarly inoculated and were housed
separately for virus titration and histopathology in organs. At 23 h
p.i., each of the three remaining donor ferrets was housed in a
cage with one naı¨ve direct-contact ferret (n = 3). An additional
ferret (n = 3) was placed in an adjacent cage separated from the
donor’s cage by a two layers of wire mesh (,5 cm apart) that
prevented physical contact but allowed the passage of respiratory
droplets. Clinical signs of infection, relative inactivity index [53],
weight, and temperature were recorded on days 0, 3, 5, 7, and 10
p.i.. Nasal washes were collected from ferrets 3, 5, 7, and 10 days
p.i. Two donor animals were euthanized 5 dpi, and tissue samples
were collected. Samples were homogenized and virus was titrated
(log10 TCID50 per gram of tissue) in ST cells. Tissues were also
subjected to histopathologic analysis.
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Assessment of virus pathogenicity and transmission in
swine
Swine challenge studies were performed at Newport Laborato-
ries under biosafety level 2 conditions. Twenty-eight swine
approximately 10 weeks of age were obtained from a commercial
high-health herd. Eleven swine were placed in a single room and
inoculated intranasally with 6.0 log10 TCID50 of C/OK. On day 1
p.i., 11 naı¨ve direct-contact swine were introduced into the room.
Temperatures were recorded and nasal swabs were collected on
days 0, 2, 3, 6, 8, and 10 p.i. Six inoculated swine and three mock-
inoculated swine were euthanized on day 7 p.i. and lung
specimens were fixed in 10% neutral buffered formalin and
submitted for histopathological analysis. The remaining swine
were euthanized on day 14 p.i. Nasal swabs and lung tissue were
analyzed by rt-RT-PCR as described above.
Structural modeling
The structure of C/OK HE (aa 17–620) was modeled using
Modeller 9.10 [54]. The structure of C/Johannesburg/1/66 HE
was used as template (PDB id: 1FLC) [36] because the two HE
proteins show both high sequence and secondary structure
similarity. The quality of the modeled structure was estimated
by Verify_3D and 95.47% of the modeled residues are compatible
with the structure (averaged 3D-1D score .0.2) [55], suggesting
that the quality of the modeling is good. The distance between the
modeled structure and template is 0.49 angstrom. Electrostatic
surface maps were generated using APBS [56].
Supporting Information
Figure S1 rt-RT-PCR Ct values of nasal swabs from
swine inoculated intranasally with C/OK (donors) and
from swine exposed to inoculated swine by direct
contact. Numbers of pigs positive by rt-RT-PCR are indicated
above or below each time point.
(TIFF)
Figure S2 Growth of influenza C/swine/Oklahoma/
1334/2011 (A) and influenza C/Taylor/1233/1947 (B) in
cell cultures. ST, MDCK, Marc145, PK or -15, BHK-21,
HRT-18G and A549 cell lines were inoculated with approximately
1.0–3.0 log10 TCID50/mL of influenza C/OK virus or influenza
C/Taylor virus (MOI= 161025–161023). Virus was titrated at
the indicated time points by rt-RT-PCR. Experiments were done
in duplicate; values are the mean of duplicate samples and error
bars represent the standard deviation.
(TIF)
Figure S3 Modeled structure of C/OK HE protein.
Cartoon and surface representations of HE structure are shown
below. HE was colored blue. Residues that are not identical in C/
Johannesburg/1/66 HE were marked red. An analog of 9-O-sialic
acid, 9-acetamindo-sialic acid a-methylglycoside (cyan), was
manually docked to the binding sites of receptor and esterase
domain according to a previous study [36].
(TIFF)
Figure S4 Sequence alignment and secondary structure
of HE protein. Sequences were aligned using MUSCLE [57].
Esterase active site residues and receptor binding site residues of
human influenza C HE protein are marked with red and blue
rectangles, respectively. Secondary structure of C/OK HE was
predicted using PSIpred while that of human influenza C HE
protein is from PDB structure (1FLC) [58]. Pink rectangles
represent a helix, orange arrows represent b strands and black
lines are random coils and loops.
(TIF)
Table S1 Sequences of the 39 and 59 noncoding regions
of the genomic segments of C/swine/Oklahoma/1334/
2011 (A) and C/JHB/1/66 (B).
(DOCX)
Table S2 Cross-reactivity of antibodies to influenza A, B
and C viruses and C/swine/Oklahoma/1334/2011 virus
as measured by HI assay using turkey red blood cells.
(DOCX)
Text S1 Supplementary Materials and Methods.
(DOC)
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